Original Research
Accepted on 27 Oct 2025
C-Reactive Protein Flare: A Promising Prognostic Predictor for Patients with Hepatocellular Carcinoma Treated with TACE Combined with Lenvatinib and Immune Checkpoint Inhibitors
in Cancer Immunity and Immunotherapy
- 142 views